Various Dermatoses What the Patients with Cutaneous Melanoma Had Anxiety for the Recurrence During Postoperative Surveillance

Overview

Journal Ann Dermatol

Specialty Dermatology

Date 2017 Aug 2

PMID 28761291

Citations 1

Authors

Hyun-Joo Lee

Hyunju Jin

Hyang-Suk You

Woo-Haing Shim

Jeong-Min Kim

Gun-Wook Kim

Je-Ho Mun

Hoon-Soo Kim

Hyun-Chang Ko

Byung-Soo Kim

Moon-Bum Kim

Affiliations

Soon will be listed here.

Abstract

Background: The incidence and mortality rates associated with cutaneous melanoma (CM) have steadily increased over the last 20 years. Even with successful treatment, melanoma patients usually experience substantial anxiety regarding the development of terrible recurrence. To date, few studies have investigated various ().

Objective: To describe various and to evaluate the risk of subsequent malignant skin disease in patients with CM.

Methods: We performed a prospective study between August 2002 and August 2015.

Results: Fifty-six patients presented with a total of 68 . Among them, melanocytic nevus was the most common (n=27), followed by seborrheic keratosis (n=9) and CM recurrence (n=7). Approximately 5.6% of the lesions were diagnosed as malignant skin diseases. This was a single-center study, so the prevalence of malignant skin diseases following primary melanoma may not represent that of all patients with CM.

Conclusion: The results of this study can be referred by dermatologists dealing with melanoma especially when CM patients have too excessive or unrealistic anxiety for melanoma recurrence during postoperative surveillance of CM. However, the importance of postoperative surveillance must still be emphasized because of real risk of melanoma recurrence and other malignant skin.

Citing Articles

Safety of photodynamic therapy combined with surgical excision in patients with actinic keratosis and risk factors for secondary cutaneous squamous cell carcinoma.

Yi Q, Liu J Am J Transl Res. 2023; 15(5):3548-3555.

PMID: 37303615 PMC: 10251020.

References

Veronesi U, Cascinelli N, Bufalino R . Evaluation of the risk of multiple primaries in malignant cutaneous melanoma. Tumori. 1976; 62(1):127-30. DOI: 10.1177/030089167606200114. View

Korfage I, Essink-Bot M, Janssens A, Schroder F, de Koning H . Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. Br J Cancer. 2006; 94(8):1093-8. PMC: 2361242. DOI: 10.1038/sj.bjc.6603057. View

Urist M, Balch C, Soong S, Shaw H, Milton G, Maddox W . The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma. Cancer. 1985; 55(6):1398-402. DOI: 10.1002/1097-0142(19850315)55:6<1398::aid-cncr2820550639>3.0.co;2-a. View

Garbe C, Buttner P, Weiss J, Soyer H, Stocker U, Kruger S . Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol. 1994; 102(5):695-9. DOI: 10.1111/1523-1747.ep12374280. View

Tucker M, Halpern A, Holly E, Hartge P, Elder D, Sagebiel R . Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA. 1997; 277(18):1439-44. View

Dancey A, Rayatt S, Courthold J, Roberts J . Views of UK melanoma patients on routine follow-up care. Br J Plast Surg. 2005; 58(2):245-50. DOI: 10.1016/j.bjps.2004.10.012. View

Brobeil A, Rapaport D, Wells K, Cruse C, Glass F, Fenske N . Multiple primary melanomas: implications for screening and follow-up programs for melanoma. Ann Surg Oncol. 1997; 4(1):19-23. DOI: 10.1007/BF02316806. View

Jung G, Dover D, Salopek T . Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009. Br J Dermatol. 2014; 170(1):136-43. DOI: 10.1111/bjd.12694. View

DiFronzo L, Wanek L, Elashoff R, Morton D . Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol. 1999; 6(7):705-11. DOI: 10.1007/s10434-999-0705-0. View

10.

Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T . Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer. 1996; 73(2):255-9. PMC: 2074325. DOI: 10.1038/bjc.1996.45. View

11.

van der Velden H, van Rossum M, Blokx W, Boezeman J, Gerritsen M . Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients. Dermatol Res Pract. 2010; 2009:479183. PMC: 2879611. DOI: 10.1155/2009/479183. View

12.

Cohn-Cedermark G, Mansson-Brahme E, Rutqvist L, Larsson O, Singnomklao T, Ringborg U . Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study. Cancer. 1997; 80(8):1418-25. View

13.

Holly E, Kelly J, Shpall S, Chiu S . Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol. 1987; 17(3):459-68. DOI: 10.1016/s0190-9622(87)70230-8. View

14.

Coit D, Andtbacka R, Bichakjian C, Dilawari R, DiMaio D, Guild V . Melanoma. J Natl Compr Canc Netw. 2009; 7(3):250-75. DOI: 10.6004/jnccn.2009.0020. View

15.

Korta D, Saggar V, Wu T, Sanchez M . Racial differences in skin cancer awareness and surveillance practices at a public hospital dermatology clinic. J Am Acad Dermatol. 2013; 70(2):312-7. DOI: 10.1016/j.jaad.2013.10.030. View

16.

Themstrup L, Jemec G, Lock-Andersen J . Patients highly value routine follow-up of skin cancer and cutaneous melanoma. Dan Med J. 2013; 60(10):A4713. View

17.

Garbe C, McLeod G, Buettner P . Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer. 2000; 89(6):1269-78. DOI: 10.1002/1097-0142(20000915)89:6<1269::aid-cncr11>3.0.co;2-c. View

18.

Tsao H, Bevona C, Goggins W, Quinn T . The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. Arch Dermatol. 2003; 139(3):282-8. DOI: 10.1001/archderm.139.3.282. View

19.

Stang A, Stang K, Stegmaier C, Hakulinen T, Jockel K . Skin melanoma in Saarland: incidence, survival and mortality 1970-1996. Eur J Cancer Prev. 2001; 10(5):407-15. DOI: 10.1097/00008469-200110000-00004. View

20.

Cruse C, Wells K, Schroer K, Reintgen D . Etiology and prognosis of local recurrence in malignant melanoma of the skin. Ann Plast Surg. 1992; 28(1):26-8. DOI: 10.1097/00000637-199201000-00009. View